Prevention and Management of Hepatitis B in Healthcare Professionals

被引：6

作者：

O’Brien C.R. ^{[1
]}

Lim J.K. ^{[2
]}

机构：

[1] Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, LMP 1080, New Haven, 06520-8019, CT

[2] Yale Liver Center and Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT

来源：

Current Hepatology Reports | 2019年 / 18卷 / 1期

关键词：

Healthcare professionals; Hepatitis B; Needlestick injury; Occupational health; Vaccination;

D O I：

10.1007/s11901-019-00444-6

中图分类号：

学科分类号：

摘要：

Purpose of Review: To review the epidemiology of hepatitis B virus (HBV) transmission in the healthcare setting and outline best practices in the prevention and management of chronic HBV in healthcare professionals. Recent Findings: Hepatitis B virus (HBV) infection remains a global public health burden and chronically infects an estimated 257 million persons worldwide. HBV represents one of the most important occupational risks for healthcare workers (HCWs) due to efficient transmission through percutaneous exposure of HBV-infected blood and blood-contaminated body fluids. Although the incidence of HCW-patient transmission of HBV has decreased significantly since 2000, ongoing deficits in HCW testing, vaccination, and confirmation of immunity, as well as post-exposure management protocols, raise concern for ongoing risk for nosocomial exposure. Summary: Established recommendations of the AASLD, CDC, and SHEA provide guidance to clinicians on the prevention and management of chronic HBV in healthcare professionals. © Springer Science+Business Media, LLC, part of Springer Nature 2019.

引用

页码：1 / 8

页数：7

共 44 条

[21]

Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings, MMWR Morb Mortal Wkly Rep, 37, pp. 377-382, (1988)

[22]

Schillie S., Vellozzi C., Reingold A., Harris A., Haber P., Ward J.W., Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, MMWR Recomm Rep, 67, 1, pp. 1-31, (2018)

[23]

Bond W.W., Favero M.S., Petersen N.J., Gravelle C.R., Ebert J.W., Maynard J.E., Survival of hepatitis B virus after drying and storage for one week, Lancet, 317, pp. 550-551, (1981)

[24]

Maniar H., Tawari A., Suk M., Bowen T., Horwitz D., Percutaneous and mucocutaneous exposure among orthopedic surgeons: immediate management and compliance with CDC protocol, J Orthop Trauma, 29, 10, pp. 391-395, (2015)

[25]

Byrd K.K., Lu P.J., Murphy T.V., Hepatitis B vaccination coverage among health-care personnel in the United States, Public Health Rep, 128, pp. 498-509, (2013)

[26]

Recommendation of the Immunization Practices Advisory Committee (ACIP): inactivated hepatitis B virus vaccine, MMWR Morb Mortal Wkly Rep, 31, pp. 317-322, (1982)

[27]

Tatelbaum M.F., Needlestick safety and prevention act, Pain Physician, 4, pp. 193-195, (2001)

[28]

Update on adult immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 40, pp. 1-94, (1991)

[29]

Terrault N.A., Lok A.S.F., McMahon B.J., Chang K.M., Hwang J.P., Jonas M.M., Et al., Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance, Hepatology, 67, pp. 1560-1569, (2018)

[30]

Tohme R.A., Ribner B., Huey M.J., Spradling P.R., Hepatitis B vaccination coverage and documented seroprotection among matriculating healthcare students at an academic institution in the United States, Infect Control Hosp Epidemiol, 32, pp. 818-821, (2011)

← 1 2 3 4 5 →